Evidence map›Paper›PMID 35425144›Full record

ArticleRSC advances2021

Targeted specific inhibition of bacterial and

Monica Pandey, Kirti Wasnik, Shubhra Gupta, Monika Singh, Sukanya Patra, Premshankar Gupta, Divya Pareek, Somedutta Maity, Ragini Tilak, Pradip Paik

Abstract read
In one paragraph

Article in RSC advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Metal Nanoparticles to CombatMicroorganisms · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Monica PandeySchool of Engineering Sciences and Technology, University of Hyderabad Telangana 500046 India.
Kirti WasnikSchool of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India paik.bme@iitbhu.ac.in.
Shubhra GuptaSchool of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India paik.bme@iitbhu.ac.in.
Monika SinghSchool of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India paik.bme@iitbhu.ac.in.
Sukanya PatraSchool of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India paik.bme@iitbhu.ac.in.
Premshankar GuptaSchool of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India paik.bme@iitbhu.ac.in.
Divya PareekSchool of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India paik.bme@iitbhu.ac.in.
Somedutta MaitySchool of Engineering Sciences and Technology, University of Hyderabad Telangana 500046 India.
Ragini TilakInstitute of Medical Sciences, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India.
Pradip PaikSchool of Biomedical Engineering, Indian Institute of Technology, Banaras Hindu University (BHU) Varanasi Uttar Pradesh 221005 India paik.bme@iitbhu.ac.in.ORCID https://orcid.org/0000-0001-7033-0636

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive bacterial and fungal infections have notably increased the burden on the health care system and especially in immune compromised patients. These invasive bacterial and fungal species mimic and interact with the host extracellular matrix and increase the adhesion and internalization into the host system. Further, increased resistance of traditional antibiotics/antifungal drugs led to the demand for other therapeutics and preventive measures. Presently, metallic nanoparticles have wide applications in health care sectors. The present study has been designed to evaluate the advantage of Ag/Sn-SnO

Identifiers

PMID35425144
PMCPMC8978812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.